BioSpace News Archive

Press Releases

Ipsen – Half year statement – 2025 12 31

January 7, 2026
·
5 min read
Press Releases

Aperture Therapeutics Announces First-In-Class MMP9 Antisense Oligonucleotide Program for ALS

January 7, 2026
·
3 min read
Press Releases

Espervita’s EVT0185 Demonstrates Reversal of Metabolic Dysfunction and Liver Fibrosis in Cell Metabolism Publication

January 7, 2026
·
2 min read
Press Releases

Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit

January 7, 2026
·
14 min read
Press Releases

Brenus Pharma Reports Favorable Tolerability and Clinical Signals in Early Preliminary Results of First-In-Human Study for STC-1010 in Unresectable Metastatic Stage Colorectal Cancer (MSS CRC) Patients

January 7, 2026
·
2 min read
Press Releases

Estrella Immunopharma Announces Closing of $8.0 Million Registered Direct Offering and Concurrent Private Placement

January 7, 2026
·
5 min read
Press Releases

Advances in maternal-fetal and neonatal diagnostics highlighted in special January issue of ADLM’s Clinical Chemistry journal

January 7, 2026
·
4 min read
Press Releases

UBC Acquires Evidinno Outcomes Research, Expanding Real-World Evidence and HEOR Capabilities

January 7, 2026
·
2 min read
Press Releases

Stoke Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 7, 2026
·
1 min read
Press Releases

Praxis Precision Medicines, Inc. Announces Proposed Public Offering

January 7, 2026
·
4 min read